Rep. Frank Pallone Jr, D-New Jersey, who is set to be chairman of the Energy and Commerce Committee, supports the concept of a single-payer “Medicare-for-all” bill in the next Congress, but said the votes aren’t there and there are other priorities; an emergency department doctor was shot and killed by her former fiancé at Mercy Hospital in Chicago, along with a first-year pharmacy resident and a city police officer who rushed into the chaos; Kaleo, which sells a voice-activated auto-injector device that delivers a version of naloxone, raised the price of its opioid antidote product by more than 600% between 2014 and 2017.
Rep. Frank Pallone Jr, D-New Jersey, who is set to be chairman of the Energy and Commerce Committee, supports the concept of a single-payer “Medicare-for-all” bill in the next Congress, but said the votes aren’t there and there are other priorities, according to Roll Call. Pallone wants to focus on strengthening the 2010 Affordable Care Act and addressing prescription drug prices, including by allowing Medicare to negotiate drug prices. Progressives in the House are calling for a vote and their push could earn more attention over the next 2 years as Democratic candidates begin vying to take on President Donald Trump in 2020.
An emergency department (ED) doctor was shot and killed Monday by her former fiancé at Mercy Hospital in Chicago, along with a first-year pharmacy resident and a city police officer who rushed into the chaos, The Chicago Tribune reported. Tamara O’Neal, 38, graduated from the University of Illinois College of Medicine in Chicago in 2016 and had worked as a resident at Mercy for 2 years, the paper said. Police were called to the hospital after the assailant confronted O’Neal over their relationship, shooting her multiple times.
Kaleo, which sells a voice-activated auto-injector device that delivers a version of naloxone, raised the price of its opioid antidote product by more than 600% between 2014 and 2017, according to a lengthy report from the Senate Permanent Subcommittee on Investigations. The increase cost the federal government more than $142 million, STAT News reported. The small company subsidized patients who were given its Evzio opioid antidote device at no cost, instead of contracting with pharmacy benefit managers and insurers. In turn, it counted on private and public insurers to pay an increasing wholesale or list price. Kaleo began selling the device in July 2014 at $575 per unit; it is now $4100. A lower-cost alternative known as Narcan is available for $125.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More